Experimental inhibition of the (pro)renin receptor [(P)RR] is a promising therapeutic strategy in different disease models ranging from cardiorenal to oncological entities. Here, we briefly review the direct protein-protein interaction partners of the (P)RR and the plethora of distinct diseases in which the (P)RR is involved. The first structural work on the (P)RR using AlphaFold, which was recently published by Ebihara et al., is the center of this mini-review since it can mechanistically link the protein-protein interaction level with the pathophysiological level. More detailed insights into the 3D structure of the (P)RR and its interaction domains might guide drug discovery on this novel target. Finally, antibody- and small molecule-based approaches to inhibit the (P)RR are shortly discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/0113894501250617231016052930 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: (Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway.
Front Pharmacol
December 2024
Department of Cardiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
[This corrects the article DOI: 10.3389/fphar.2024.
View Article and Find Full Text PDFElevated Plasma Soluble (Pro)renin receptor as a potential indicator for heart failure.
Peptides
December 2024
Translational Medicine Centre, Jiangxi University of Chinese Medicine, Nanchang 330004, China. Electronic address:
Increasing evidence has demonstrated that sPRR [a truncated soluble form of (pro)renin receptor] levels may reflect the severity of several diseases, including kidney disease, hypertension, and heart failure (HF). Although previous studies using cohorts primarily consisting of HF patients with reduced ejection fraction revealed that increased plasma sPRR levels may be a promising evaluative indicator for HF, definitive information on the relationship between plasma sPRR levels and HF patients with preserved ejection fraction (HFpEF) is still insufficient and scarce. In the present study, we further clarified the status of plasma sPRR levels in HF patients by meta-analysis.
View Article and Find Full Text PDFSoluble (pro)renin receptor (s(P)RR) levels in women carrying Aboriginal and/or Torres Strait Islander babies; the Gomeroi Gaaynggal study.
Pregnancy Hypertens
December 2024
School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia; Women's Health Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia. Electronic address:
Objective: To determine the levels of soluble (pro)renin receptor (s(P)RR) in women carrying Aboriginal and/or Torres Strait Islander (First Nations) babies and investigate whether s(P)RR levels change in women who have complicated pregnancies.
Study Design: Cross-sectional analysis of data (2010-2018). Data/samples were from the Gomeroi Gaaynggal Study, a longitudinal cohort study based on Gomeroi/Kamilaroi lands (Tamworth), NSW, Australia.
(Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway.
Front Pharmacol
October 2024
Department of Cardiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Introduction: As one of the most common complications of diabetes, diabetic cardiomyopathy (DCM) is the main cause of heart failure in patients with diabetes. However, the lack of effective treatments for DCM remains a clinical challenge. (Pro) renin receptor (PRR) is a member of renin angiotensin aldosterone system (RAAS).
View Article and Find Full Text PDFSoluble (Pro)Renin Receptor as a Novel Regulator of Renal Medullary Na Reabsorption.
Am J Physiol Renal Physiol
November 2024
Department of Nephrology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Article Synopsis
- - Epithelial sodium channel (ENaC) plays a crucial role in sodium reabsorption, primarily in the cortical collecting duct, while its activity in the inner medulla is often overlooked.
- - The (pro)renin receptor (PRR), a new player in the renin-angiotensin system, influences ENaC regulation, specifically by boosting the activity of the α-ENaC subunit in the renal inner medulla.
- - Soluble PRR (sPRR) enhances ENaC function through mechanisms involving Nox4-derived hydrogen peroxide and is particularly significant during overactivity of the renin-angiotensin-aldosterone system (RAAS).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!